South Sudan vs Togo: Death rate from cancer
South Sudan
41.45 deaths per 100,000 people
in 2021
Togo
43.28 deaths per 100,000 people
in 2021
South Sudan rank
174th
Togo rank
171st
Death rate from cancer over time
- South Sudan
- Togo
How they compare
Togo currently reports 43.28 deaths per 100,000 people against 41.45 deaths per 100,000 people in South Sudan, a difference of 1.83 deaths per 100,000 people.
Across all 22 years both countries report, Togo has been ahead every year.
South Sudan ranks 174th and Togo ranks 171st of 194 countries.
Togo has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | South Sudan | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 36.27 deaths per 100,000 people | 41.54 deaths per 100,000 people | 5.27 deaths per 100,000 people | Togo |
| 2010s | 40.56 deaths per 100,000 people | 45.93 deaths per 100,000 people | 5.37 deaths per 100,000 people | Togo |
| 2020s | 40.95 deaths per 100,000 people | 44.39 deaths per 100,000 people | 3.44 deaths per 100,000 people | Togo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher death rate from cancer, South Sudan or Togo?
- Togo, at 43.28 deaths per 100,000 people against 41.45 deaths per 100,000 people in South Sudan as of 2021.
- What is the difference in death rate from cancer between South Sudan and Togo?
- 1.83 deaths per 100,000 people, with Togo ahead.
- How many years of comparable data are there for South Sudan and Togo?
- 22 years are reported by both, from 2000 to 2021.
- How do South Sudan and Togo rank globally for death rate from cancer?
- South Sudan ranks 174th and Togo ranks 171st of 194 countries.
- Where does this data come from?
- World Health Organization (2024) – with major processing by Our World in Data, published as Death rate from cancer. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from malignant neoplasms in both sexes, per 100,000 people.